Evidence map›Paper›PMID 26958241›Full record

ArticleAMIA ... Annual Symposium proceedings. AMIA Symposium2015

Approaches to Supporting the Analysis of Historical Medication Datasets with RxNorm.

Lee B Peters, Olivier Bodenreider

Abstract read
In one paragraph

Article in AMIA ... Annual Symposium proceedings. AMIA Symposium, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The Drug Data to Knowledge Pipeline: Large-Scale Claims Data Classification for Pharmacologic Insight.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Lee B PetersNational Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA.
Olivier BodenreiderNational Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA.

Funding

Drug terminology at NLM - Integration, dissemination, quality assurance and applicationsZIALM010007 · NLM · NATIONAL LIBRARY OF MEDICINE · PI BODENREIDER, OLIVIER · 2016 to 2020
$3.1M
6 · The paper itself

Abstract

objectiveTo investigate approaches to supporting the analysis of historical medication datasets with RxNorm.

methodsWe created two sets of National Drug Codes (NDCs). One is based on historical NDCs harvested from versions of RxNorm from 2007 to present. The other comprises all sources of NDCs in the current release of RxNorm, including proprietary sources. We evaluated these two resources against four sets of NDCs obtained from various sources.

resultsIn two historical medication datasets, 14-19% of the NDCs were obsolete, but 91-96% of these obsolete NDCs could be recovered and mapped to active drug concepts.

conclusionAdding historical data significantly increases NDC mapping to active RxNorm drugs. A service for mapping historical NDC datasets leveraging RxNorm was added to the RxNorm API and is available at https://rxnav.nlm.nih.gov/.

Indexed as

Computer SystemsRxNormVocabulary, ControlledHumans

Identifiers

PMID26958241
PMCPMC4765580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.